The incidence of encephalopathy is increased with prescription of higher versus lower doses of baclofen among older patients with chronic kidney disease.
Researchers reported the safety and efficacy of a novel miniaturized neurostimulator, the first-in-human, double-blind pilot study of vagus nerve stimulation, in patients with multidrug refractory rheumatoid arthritis.
Researchers highlighted the need for rapid investigations of vaccine safety concerns to use robust epidemiologic methods to maintain public and professional confidence in vaccination programs.
Clariscan is a macrocyclic, gadolinium-based contrast agent, for intravenous use with magnetic resonance imaging in brain (intracranial), spine and associated tissues in adult and pediatric patients.
The Warnings and Precautions section has been updated to address the potential for late-onset neurotoxicity, including ataxia and encephalopathy with efavirenz treatment.
This study provides normative values for the bilateral lumbar and sacral-anorectal MEPs in healthy subject with no age or gender influence on rectal or anal MEP latency.
Evidence suggests that even after optimal treatment with surgical and pharmacologic interventions, health-related quality of life remains impaired in patients with pituitary disease.
Company claimed their CBD products can be used to treat a variety of conditions and diseases including teething pain and earaches in infants, skin problems, autism, ADHD, Parkinson disease, and Alzheimer disease, among others.
This case aims to remind physicians of novel pathogens emerging as a cause of endocarditis and to have a high clinical suspicion of endocarditis in patients with predisposing risk factors.
Based on results from the phase 1/2 trial, FX-322 was found to be safe and well-tolerated with no serious adverse events.